Canada markets open in 7 hours 3 minutes

Satellos Bioscience Inc. (MSCL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.2550+0.0050 (+2.00%)
At close: 03:50PM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 10.45M
Enterprise Value 10.83M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.27
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 4.42

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-79.17%
S&P500 52-Week Change 3-13.12%
52 Week High 31.3600
52 Week Low 30.2200
50-Day Moving Average 30.2886
200-Day Moving Average 30.5634

Share Statistics

Avg Vol (3 month) 343.16k
Avg Vol (10 day) 324.88k
Shares Outstanding 541.8M
Implied Shares Outstanding 6N/A
Float 834.23M
% Held by Insiders 19.31%
% Held by Institutions 114.41%
Shares Short (Nov 14, 2022) 465.35k
Short Ratio (Nov 14, 2022) 41.89
Short % of Float (Nov 14, 2022) 4N/A
Short % of Shares Outstanding (Nov 14, 2022) 40.16%
Shares Short (prior month Oct 13, 2022) 424.13k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Aug 17, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-39.53%
Return on Equity (ttm)-85.96%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-8.78M
Diluted EPS (ttm)-0.6040
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.13M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.68
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-5.78M
Levered Free Cash Flow (ttm)-1.88M